Results 11 to 20 of about 101,265 (243)

Carbapenem-Resistant Enterobacteriaceae [PDF]

open access: yesClinics in Laboratory Medicine, 2017
Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as a major threat. Commonly used antibiotics are generally inactive against CRE. Therefore, timely detection of CRE is of paramount importance. Among CRE, those producing carbapenem-hydrolyzing β-lactamase enzymes (carbapenemase-producing Enterobacteriaceae) are particularly of concern because ...
Alina, Iovleva, Yohei, Doi
  +7 more sources

Risk factors for linezolid-associated thrombocytopenia and negative effect of carbapenem combination

open access: yesJournal of Infection in Developing Countries, 2019
Introduction: Linezolid is a synthetic antimicrobial agent with a broad spectrum of activity against virtually all Gram-positive bacteria. Although linezolid is generally well tolerated, the prolonged use of linezolid can lead to myelosuppression ...
Esra Kaya Kılıç   +7 more
doaj   +1 more source

Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study [PDF]

open access: yes, 2018
Background: The number of infections caused by resistant organisms is largely unknown. We estimated the number of infections worldwide that are caused by the WHO priority pathogens third-generation cephalosporin-resistant and carbapenem-resistant ...
Almagor, Jonatan   +5 more
core   +1 more source

Parenteral carbapenems [PDF]

open access: yesClinical Microbiology and Infection, 2008
Among the many different structurally distinct classes of beta-lactams, the carbapenem class is regarded as that which is most potent and which has the widest spectrum of antimicrobial activity. Rapidly bactericidal, and demonstrating time-dependent killing, carbapenemes have a spectrum of antimicrobial activity that includes Gram-positive and Gram ...
openaire   +2 more sources

A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients

open access: yesJournal of Infection in Developing Countries, 2016
Introduction: Carbapenem-resistant Klebsiella pneumoniae (CRKP) is rapidly emerging as a life-threatening nosocomial infection. In this study, we aim to identify risk factors, especially antibiotic use, for CRKP infection among intensive care unit (ICU ...
Yangmin Hu   +5 more
doaj   +1 more source

Appropriate use of colistin in neonates, infants and children: Interim guidance

open access: yesSouthern African Journal of Infectious Diseases, 2023
No abstract available.
Vindana Chibabhai   +10 more
doaj   +1 more source

Severe bloodstream infection due to KPC-producer e coli in a renal transplant recipient treated with the double-carbapenem regimen and analysis of in vitro synergy testing a case report [PDF]

open access: yes, 2016
Transplant recipients are at high risk of infections caused by multidrug resistant microorganisms. Due to the limited thera- peutic options, innovative antimicrobial combinations against carbape- nem-resistant Enterobacteriaceae causing severe infections
CIPOLLA, ALESSIA   +11 more
core   +1 more source

A 5-year retrospective study of antibiotic resistance pattern of Pseudomonas aeruginosa isolated from various clinical samples at a tertiary care hospital

open access: yesMedical Journal of Dr. D.Y. Patil Vidyapeeth, 2023
Objective: Pseudomonas aeruginosa is a common cause of nosocomial infections worldwide. Increasing in the emergence and spread of multidrug-resistant (MDR) strains is a serious health concern.
Mohan Bilikallahalli Sannathimmappa   +2 more
doaj   +1 more source

Assessment of In Vitro Cefiderocol Susceptibility and Comparators against an Epidemiologically Diverse Collection of Acinetobacter baumannii Clinical Isolates

open access: yesAntibiotics, 2022
Cefiderocol is a catechol-substituted siderophore cephalosporin combining rapid penetration into the periplasmic space with increased stability against β-lactamases.
Clara Ballesté-Delpierre   +5 more
doaj   +1 more source

Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis [PDF]

open access: yes, 2018
Background: Infections due to antibiotic-resistant bacteria are threatening modern health care. However, estimating their incidence, complications, and attributable mortality is challenging.
Abu Sin, Muna   +79 more
core   +6 more sources

Home - About - Disclaimer - Privacy